newsfilter
← Latest News
GlobeNewswire·

Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

FOSTER CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to